Dataset Information


Obesity and Outcomes in COVID-19: When an Epidemic and Pandemic Collide.

ABSTRACT: Obesity has reached epidemic proportions in the United States and in much of the westernized world, contributing to considerable morbidity. Several of these obesity-related morbidities are associated with greater risk for death with coronavirus disease 2019 (COVID-19). Severe acute respiratory syndrome coronavirus 2 penetrates human cells through direct binding with angiotensin-converting enzyme 2 receptors on the cell surface. Angiotensin-converting enzyme 2 expression in adipose tissue is higher than that in lung tissue, which means that adipose tissue may be vulnerable to COVID-19 infection. Obese patients also have worse outcomes with COVID-19 infection, including respiratory failure, need for mechanical ventilation, and higher mortality. Clinicians need to be more aggressive when treating obese, especially severely obese, patients with COVID-19 infection.

PROVIDER: S-EPMC7236707 | BioStudies |

REPOSITORIES: biostudies

Similar Datasets

| S-EPMC7896878 | BioStudies
| S-EPMC7887545 | BioStudies
| S-EPMC7227557 | BioStudies
| S-EPMC7497736 | BioStudies
2022-07-25 | GSE208034 | GEO
| S-EPMC7337756 | BioStudies
| S-EPMC8450706 | BioStudies
| S-EPMC7882857 | BioStudies
| S-EPMC7341421 | BioStudies
| S-EPMC7805556 | BioStudies